Construction and Policy Recommendations for An Integrated Pharmaceutical Care Model for Chronic Respiratory Diseases Based on the Rainbow Model
10.3870/j.issn.1004-0781.2024.07.027
- VernacularTitle:基于彩虹模型的慢性呼吸系统疾病整合型药学服务模式构建与政策建议
- Author:
Dan ZHONG
1
;
Chunming LI
;
Xue YANG
;
Shuangshuang HE
;
Dong LI
;
Haiyan XING
Author Information
1. 陆军特色医学中心(大坪医院)药剂科,重庆 400042
- Keywords:
Integrated pharmaceutical care;
Chronic respiratory diseases;
Hierarchical medical system;
Rainbow model;
Policy recommendations
- From:
Herald of Medicine
2024;43(7):1165-1170
- CountryChina
- Language:Chinese
-
Abstract:
Objective To construct an integrated pharmaceutical care model for chronic respiratory system disease patients,and to provide policy recommendations.Methods A field survey,a semi-structured interview,and a questionnaire survey were comprehensively used to investigate the effect of the reform and the status quo of pharmaceutical care for chronic respiratory diseases after the medicine consistency reform in the medical alliance of Chongqing.Subsequently,the rainbow model was used to assess the challenges in the macro,meso,micro,and supporting element's dimensions,and the integrated pharmaceutical care model was established as a consequence.Results The primary issues involved in the medical alliance were as followed:insufficient joint reformation for public health services,medical insurance,and medical production and circulation(JRPMM);deficient supporting policies;a dearth of information support;an inadequately list of medications;insufficient collaboration among chronic disease specialties;and unstandardized pharmaceutical care.Consequently,the following recommendations were:in the macro dimension,to strengthen the JRPMM to enhance the service capacity of primary hospitals and to develop suitable human resource coordination mechanisms.In the meso dimension,to intensify the reform of pharmaceutical care in the medical alliance and enhance specialty collaboration horizontally.In the micro dimension,to establish a pharmaceutical management committee in the medical alliance,to formulate pharmaceutical technical specifications for the hierarchical medical system,and to combine"talent and technology"training innovatively.In the supporting elements dimension,to bolster information support in the area and to develop suitable incentives and assessment institutions.Conclusion This paper reported an integrated pharmaceutical care model for chronic respiratory diseases,which could serve as a reference for standardizing the hierarchical medical system for chronic diseases.
